Navigation Links
Roka Bioscience to Report Second Quarter 2014 Financial Results On August 11, 2014
Date:8/4/2014

WARREN, N.J., Aug. 4, 2014 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the second quarter of 2014 on August 11, 2014 before the open of the financial markets.

Roka Bioscience will also host a conference call at 8:30 a.m. Eastern Time on August 11, 2014 to discuss its second quarter financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call live, go to http://rokabio.investorroom.com/ or dial 1-877-870-4263 for domestic callers and 1-412-317-0790 for international callers.  A replay of the conference call will be available after the completion of the call through August 18, 2014 by dialing 1-877-344-7529 domestic and 1-412-317-0088 international. An online archive of the conference call will also be available by accessing the Investors section of the company's website at http://rokabio.com.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. 

Contact:

Steve Sobieski
Chief Financial Officer (908) 605-4621 ssobieski@rokabio.com

Logo - http://photos.prnewswire.com/prnh/20140801/132739


'/>"/>
SOURCE Roka Bioscience, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
2. Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
3. Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
4. Ambit Biosciences To Announce Second Quarter 2014 Financial Results
5. PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages
6. Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics Targeted Next Generation Sequencing Testing Platform
7. Attention Regado Biosciences, Inc. Investors: Regado Misled Investors According to a Recently Filed Class Action
8. Meditope Biosciences Appoints Prominent Scientific Advisory Board
9. Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference
10. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
11. Coherus Biosciences als Präsentator zur J.P. Morgan Annual Healthcare Conference 2014 eingeladen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
(Date:7/6/2017)... CINCINNATI , July 6, 2017 ThriveRx, the nutrition division ... and their families to thrive on nutrition support. To celebrate ... The new site has a fresh new look with improved organization to ... ... ...
Breaking Medicine Technology:
(Date:7/22/2017)... ... July 22, 2017 , ... More than ... of patients not requiring pain medication after three months post-operatively. However, researchers presenting ... Meeting today in Toronto, Ontario, Canada found that those patients who were filling ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern Georgie provider ... in a community wide charity event with the goal of bringing in support for ... woman who lives with epilepsy, recently launched a charity campaign of her own by ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... Philadelphia and Theater of Witness , was awarded a $300,000 grant ... humanities program which fosters empathy, comfort with ambiguity and the recognition of one’s ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated ... life a decade after surgery, though activity levels decline over time. The study, ...
Breaking Medicine News(10 mins):